Skip to main content
Home
Toggle menu

Give Now

  • For Patients
  • School Of Medicine
  • About
    • Leadership
    • Department Directory
    • News
    • Events
    • Annual Report
    • Nashville
  • Divisions
    • Allergy, Pulmonary and Critical Care Medicine
    • Cardiovascular Medicine
    • Diabetes, Endocrinology and Metabolism
    • Epidemiology
    • Gastroenterology, Hepatology and Nutrition
    • General Internal Medicine and Public Health
    • Genetic Medicine and Clinical Pharmacology
    • Geriatric Medicine
    • Hematology and Oncology
    • Infectious Diseases
    • Nephrology and Hypertension
    • Rheumatology and Immunology
  • Education
    • Overview
    • Internal Medicine Residency Program
    • Physician-Scientist Training Program
    • Internal Medicine-Pediatrics Residency Program
    • Fellowship Programs
    • EXCellence In TEaching Pathway
    • Physician-Scientist Doctoral Program
    • Medical Students
    • Alumni
    • Medicine Grand Rounds
  • Research
    • Overview
    • Clinical Trials
    • Publications
    • Research Centers and Labs
  • Faculty
    • Open Faculty Positions
    • Professional Development
  • Clinical Initiatives
    • Digital Health
    • Physician Builder Program

User Detail

Justin Balko, PhD

Professor of Medicine

Division of Hematology Oncology

Co-leader, Breast Cancer Research Program

Justin Balko
Professional Bio
Justin M. Balko, PhD, PharmD, is a Professor of Medicine in the Division of Hematology and Oncology, Department of Medicine, at Vanderbilt University Medical Center. He obtained his Doctorate in Pharmacy from the State University of New York at Buffalo. After completion of his PhD in the Clinical and Experimental Therapeutics track of the Pharmaceutical Sciences program at the University of Kentucky, he joined the laboratory of Carlos L. Arteaga, MD, in 2009 as a postdoctoral research fellow. Dr. Balko is an Ingram Associate Professor of Cancer Research and Associate Professor of Medicine and Pathology, Microbiology, and Immunology, and co-leads the VICC Breast Cancer Research Program. He has published over 100 peer reviewed contributions in the field of molecular oncology and translational oncology research, primarily in the breast cancer field. His laboratory focuses on identifying biomarkers and mechanisms of drug sensitivity or resistance in breast cancer and other tumor types, ways to enhance response rates to immunotherapy by targeting cancer-specific signals of immune suppression, and the biological mechanisms of immune-related adverse events to immunotherapies. His laboratory receives or has received funding from the NIH/NCI, the Department of Defense, The IBC Network Foundation, the Jimmy V Foundation for Cancer Research, The Mary Kay Foundation, Stand Up 2 Cancer/AACR, and Susan G. Komen.
Relevant Links
VICC Profile
Publications
View Publications

Education

PharmD - University at Buffalo, State University of New York, 2004

PhD - Pharmaceutical Sciences - University of Kentucky, 2009

Fellowship - Heme/Onc - Vanderbilt University, 2013

Contact

Email 
Kimryn.Rathmell@Vumc.Org 
Address 
777 Preston Research Building 
2220 Pierce Ave 
Nashville, TN 37232-6307

Submitted by admin on Thu, 06/01/2023 - 04:28

1161 21st Ave S
Nashville, TN 37232

(615) 322-5000

Quick Links

  • Home
  • About
  • Divisions
  • Education
  • Research
  • Faculty
  • Intranet

Support Our Work

Start a fundraiser or donate to the Department of Medicine.

Give Now

Vanderbilt Health is committed to fostering an environment where everyone has the chance to thrive and is committed to the principles of equal opportunity. EOE/Vets/Disabled.

Copyright © Vanderbilt University Medical Center

sfy39587stp18